PRA Health Sciences, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Service revenue
Reimbursement revenue
Revenue
Operating expenses:
Cost of revenues
Direct costs
Reimbursable out-of-pocket costs
Reimbursable investigator fees
Cost of revenue
Direct costs
Reimbursable expenses
Selling, general and administrative expenses
Transaction-related costs
Depreciation and amortization expense
Loss on disposal of fixed assets
Income from operations
Interest expense, net
Loss on modification or extinguishment of debt
Foreign currency losses, net
Other (expense) income, net
Income before income taxes and equity in income of unconsolidated joint ventures
Provision for income taxes
Income before equity in income of unconsolidated joint ventures
Equity in income of unconsolidated joint ventures, net of tax
Net income
Net income attributable to noncontrolling interest
Net income attributable to PRA Health Sciences, Inc.
Net income per share attributable to common stockholders:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average common shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments